Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years.
Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS.
Salari K, et al. Among authors: feldman as.
J Urol. 2019 Apr;201(4):721-727. doi: 10.1097/JU.0000000000000031.
J Urol. 2019.
PMID: 30664083